A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma
Preprint in bioRxiv (December 2023)
The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.
Preprint in bioRxiv (December 2023)
Article in Expert Review of Vaccines (July 2021)
Article in Critical Reviews in Immunology (January 2021)